MSCI Denmark Index

Discussion in 'Share Investing Strategies, Theories & Education' started by oracle, 17th Apr, 2023.

Join Australia's most dynamic and respected property investment community
  1. oracle

    oracle Well-Known Member

    Joined:
    18th Jun, 2015
    Posts:
    1,465
    Location:
    Canberra
    Happen to bump into Denmark index and found it very interesting.

    Index returns (in USD)

    5 yrs = 15.65%
    10 yrs = 14.19%
    Since Dec, 1987 = 13.44%

    If you thought the above returns were impressive wait until you see it's components.

    Number of Constituents = 16 :D
    Top 10 constituents account for = 92.42% :D

    Top one holding accounts for (drum roll) = 55.97% :eek:

    The company is Novo Nordisk

    Talk about diversification ;)

    See index details - here

    Cheers,
    Oracle.
     
    Gockie and The Falcon like this.
  2. The Falcon

    The Falcon Well-Known Member

    Joined:
    18th Jun, 2015
    Posts:
    3,426
    Location:
    AU
    Some quality Biz in that mix, DSV has been a ripper over the years. The entire Nasdaq Copenhagen exchange only has about 100-150 listings from memory whereas ASX is 2000+ and that capitalisation spread across the top 10, 200B to 2B!
     
    oracle likes this.
  3. Hockey Monkey

    Hockey Monkey Well-Known Member

    Joined:
    22nd Oct, 2015
    Posts:
    1,153
    Location:
    Melbourne
    Great for Danes with a home country bias
     
  4. oracle

    oracle Well-Known Member

    Joined:
    18th Jun, 2015
    Posts:
    1,465
    Location:
    Canberra
    The good times roll on for Danish investors :D

    Stock is up over 30% last six months and over 60% last 12. months

    Full article here

    Cheers,
    Oracle.
     
  5. Paul@PAS

    Paul@PAS Tax, Accounting + SMSF + All things Property Tax Business Plus Member

    Joined:
    18th Jun, 2015
    Posts:
    23,621
    Location:
    Sydney
    Novo is copping it in some countries (USA esp) for anti-competitive behaviour for threatening pharmaceutical distributors who sell the generic semaglitude (THAT IT ALSO MAKES). This is like GSK threatening pharmacies for selling paracetamol rather than panadol. Our appalling ozempic supply (Novo also) is a consequence of this too. Novo havent been able to supply ozempic properly in three years so its claims are a bit hard to take. Meanwhile other prodcts fill the market and to counter this Novo have rebadged its product to make it sound different. Its failing as much as its performing. And instead of delivering its threatening supply chain. Wegovy is a rebadge....and so is Rybelsus. Its a cheap tablet version of ozempic.
     
  6. oracle

    oracle Well-Known Member

    Joined:
    18th Jun, 2015
    Posts:
    1,465
    Location:
    Canberra
    Seems like you think it's a good candidate to short. If your theory is sound there is money to be made, especially if the rest of the market doesn't know about it. Are you shorting it?

    Cheers,
    Oracle.